Extract inhibits enzyme linked to diseases
December 15, 2008
by Jeff Gelski
MOMENCE, ILL. — VitaCurrant black currant extract inhibited Elastase, an enzyme associated with several diseases, up to 96% at a concentration of 0.1%, according to a study conducted at FutureCeuticals, Inc. laboratories. High elastase levels have been associated with disorders such as chronic obstructive pulmonary disease (COPD), cardiovascular disease and ulcerative colitis (UC), according to FutureCeuticals.
FutureCeuticals offers VitaCurrant, a freeze-dried powder that provides 6,000 oxygen radical absorbance capacity (ORAC) units, a measure of antioxidant capacity.